ask="10.85"
ask_size="100"
average_daily_volume="192587"
bid="9.60"
bid_size="2000"
book_value="3.82"
change="+0.23"
change_from_200_day_moving_average="-0.94"
change_from_50_day_moving_average="0.05"
change_from_52_week_high="-26.07"
change_From_52_week_low="1.86"
change_in_percent="+2.38%"
close="9.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-84.11M"
eps_estimate_current_year="-2.40"
eps_estimate_next_quarter="-0.65"
eps_estimate_next_year="-2.75"
ex_dividend_date="N/A"
float_shares="20271000"
high="9.95"
high_52_weeks="35.98"
last_trade_date="3/1/2017"
last_trade_price="9.91"
last_trade_size="10321"
last_trade_time="4:00pm"
low="9.60"
low_52_weeks="8.05"
market_capitalization="399.92M"
moving_average_200_day="10.85"
moving_average_50_day="9.86"
name="Seres Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.71"
open="9.89"
pe_ratio="N/A"
peg_ratio="-0.08"
percent_change_from_200_day_moving_average="-8.64%"
percent_change_from_50_day_moving_average="+0.54%"
percent_change_from_52_week_high="-72.46%"
percent_change_from_52_week_low="+23.11%"
previous_close="9.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.54"
price_per_sales="20.86"
revenue="18.73M"
shares_outstanding="40355000"
short_ratio="14.40"
stock_exchange="NMS"
symbol="MCRB"
volume="123867"
weeks_range_52="8.05 - 35.98"
